United Therapeutics and Deka Research and Development have received FDA 510(k) clearance for the co-developed RemUnity system.
The RemUnity system is a subcutaneous delivery system for Remodulin injections. The two companies have co-developed the device that is indicated to treat pulmonary arterial hypertension.